Skip to content

Author

M. de Laurentiis

We have 4 of 416 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Abemaciclib plus endocrine therapy in high-risk, node-positive early breast cancer in Italian practice: interim analysis of prospective observational IT-PATH study

Background Abemaciclib plus endocrine therapy (ET) is an established adjuvant treatment for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, high-risk early breast cancer (EBC), based on monarchE trial. Prospective real-world data on persistence, adherence, dose m...

L. Visani, A. Melaccio, C. Vernieri et al. · 0 citations
Review Open access Aug 2026

Diagnostic and prognostic role of circular RNAs: Analytical challenges and emerging opportunities

This review examines the analytical strategies used to detect and quantify circRNAs, including amplification-based methods (RT-qPCR, droplet digital PCR, and isothermal amplification), hybridization-based assays, sequencing approaches (short- and long-read RNA-seq), and emerging biosensor technologies.

A. Glovi, P. M. Kalligosfyri, A. Miglione et al. · 0 citations
Review Open access Jul 2026

Unraveling the use of vaccine therapy in HER-2 positive breast cancer: a comprehensive review of current state and future perspectives

While advanced-stage BC often presents an immunosuppressive tumor microenvironment that hinders vaccine efficacy, early-stage disease offers a more favorable immunological milieu for inducing robust and durable T-cell responses.

A. Caltavituro, C. Martinelli, M. Palleschi et al. · 0 citations
Review Open access Jul 2026

Biosensors for Circular RNA Profiling in Biological Matrices

By bridging circRNA biology with advanced biosensor design, this work aims to accelerate translational research and guide the development of next-generation diagnostics for early disease detection, supporting a shift from reactive treatment to proactive health care.

A. Glovi, P. M. Kalligosfyri, A. Miglione et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.